Best treatment pathway initiative

This award recognises innovation in and development of existing treatment pathways in improving the patient experience and keeping patients in treatment as well as the development of new treatment pathways.

Submissions may include initiatives that promote/improve the HCV treatment pathway in primary care, in prisons and in the wider community to identify the presence of hepatitis C; increase in adherence; reduced number of appointments; improved waiting times; prompt testing and results more quickly; communication of effective pathways with other high-risk areas; monitoring.

Entries should demonstrate evidence of the following:

  • Clearly defined project scope
  • Engagement, analysis and understanding of the local community
  • Patient centricity - improved patient care and outcomes
  • Assessment of quality improvement before and after the change initiative
  • Impact on staff and/or the organisation
  • Change through innovation
  • Teamwork
  • Transferability to other areas/organisations/departments and sectors
  • Linkage back to care

Judging criteria:

ObjectivesAre the objectives clearly explained and appropriate to the initiative?0-5 points
Planning & implementationHow effective were the methods used to deliver the initiative? How well were they implemented? 0-10 points
Impact & resultsHow successful was the initiative? How well did it meet its objectives? 0-10 points
Patient experienceHow was patient experience measured and how well was the initiative received by patients?0-20 points
Audit & valuation Was the initiative subject to formal evaluation and were the measures of success appropriate? What evidence-based data exists to support the success of the programme?0-20 points
Future benefitsWhat impact does the project potentially have in the future?0-10 points
SustainabilityHow sustainable was the initiative? What level of impact has the project had (relative to available budget/resources) within its intended environment?0-10 points
ReplicationHow easily could the initiative be adapted to other health authorities?0-10 points
InnovationTo what extent was the initiative innovative or pioneering?0-5 points

  • KEY DATES FOR 2017 TO BE ANNOUNCED
QiC Hepatitis C is supported by: